ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

ClinicalTrials.gov ID: NCT00985127

Public ClinicalTrials.gov record NCT00985127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Dose-Ranging, Two-Part, Multi-Center Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

Study identification

NCT ID
NCT00985127
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
BioCryst Pharmaceuticals
Industry
Enrollment
99 participants

Conditions and interventions

Conditions

Interventions

  • BCX4208 Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 69 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2009
Primary completion
Aug 31, 2010
Completion
Aug 31, 2010
Last update posted
Jan 22, 2012

2009 – 2010

United States locations

U.S. sites
24
U.S. states
21
U.S. cities
24
Facility City State ZIP Site status
Radiant Research, Inc. Scottsdale Arizona 85251
Catalina Pointe Clinical Research Tucson Arizona 85704
Irvine Center for Clinical Research Irvine California 92618
San Diego Arthritis Medical Clinic San Diego California 92108
Avail Clinical Research DeLand Florida 32720
Anchor Research Center Naples Florida 34102
East-West Medical Research Institute Honolulu Hawaii 96814
Selah Medical Center Boise Idaho 83704
Kentucky Medical Research Center Lexington Kentucky 40504
Arthritis & Osteoporosis Center of Maryland Frederick Maryland 21702
Olive Branch Family Medical Center Olive Branch Mississippi 38654
Medex Healthcare Research St Louis Missouri 63117
Bozeman Urgent Care Center Bozeman Montana 59715
Heartland Clinical Research Omaha Nebraska 68134
Arthritis Center of Reno Reno Nevada 89502
New Mexico Clinical Research & Osteoporosis Center Albuquerque New Mexico 87106
Triangle Medical Research Associates Raleigh North Carolina 27609
STAT Research Dayton Ohio 45417
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Carolinas Center for Rheumatology & Arthritis Rock Hill South Carolina 29732
Health Concepts Rapid City South Dakota 57702
Renaissance Clinical Research Dallas Texas 75235
Northwest Clinical Research Center Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00985127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2012 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00985127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →